Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of disease pathology and therapeutic targets in severe asthma
2004-002873-21Phase 4Completed
- Sponsor
- GSK
- Start
- Feb 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of prednisolone in asthma and severe asthma, sponsored by GSK. Primary endpoints: Expression of key severe asthma targets at baseline, Expression of key biomarkers at baseline and 1 more. Started Feb 2005; status: completed.
02
Drugs
prednisolone
03
Conditions
asthmasevere asthma
Beyond the preview
Go deeper on 2004-002873-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002873-21.